Cargando…
Targeting transcription factors in cancer drug discovery
Cancer drug discovery is currently dominated by clinical trials or clinical research. Several potential drug candidates have been brought into the pipeline of drug discovery after showing very promising results at the pre-clinical level and are waiting to be tested in human clinical trials. Interest...
Autor principal: | Mitra, Partha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402400/ https://www.ncbi.nlm.nih.gov/pubmed/36046384 http://dx.doi.org/10.37349/etat.2020.00025 |
Ejemplares similares
-
Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy
por: Moustaqil, Mehdi, et al.
Publicado: (2020) -
Targeting autophagic pathways for cancer drug discovery
por: Liu, Bo, et al.
Publicado: (2013) -
Targeted Protein Degradation: An Important Tool for Drug Discovery
for “Undruggable” Tumor Transcription Factors
por: Dai, Mengyuan, et al.
Publicado: (2022) -
Antiretroviral Drug Discovery Targeting the HIV-1 Nef Virulence Factor
por: Emert-Sedlak, Lori A., et al.
Publicado: (2022) -
Drug Discovery and Development Targeting Dementia
por: Zagórska, Agnieszka, et al.
Publicado: (2023)